15 completed, 5 unknown, 3 terminated, 1 active not recruiting. 27 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 27 | Completed 15, Unknown 5, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Cefazolin: new trials by email Literature Review of Cefazolin trials Research Report on Cefazolin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin Cefazolin 2 g Infusion, Placebo infusion of .9 normal saline - Breast Cancer, Breast Surgery | Phase 3 | Not yet recruiting | University Hospital, Clermont-Ferrand | 1600 | 2026-11-01 | 2026-10-27 |
| The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients Cefazolin 1000 MG - Antibiotic Prophylaxis, Wound Infection | Phase 3 | Unknown | University of Aleppo | 200 | 2024-08-01 | 2024-08-28 |
| Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline - Staphylococcus Aureus Bacteremia | Phase 3 | Unknown | Clinical Research Centre, Malaysia | 290 | 2024-06-28 | 2024-07-05 |
| Local Antibiotics for Breast Implants Gentamicin, Cefazolin and Vancomycin, Placebo - Implant Complication, Implant Infection | Phase 3 | Active not recruiting | Mikkel Herly | 1003 | 2021-01-27 | 2026-09-29 |
| Antibioprophylaxis for Excision-graft Surgery in Burn Patient (A2B-TRIAL) active intervention, placebo intervention - Burns Surgery | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 506 | 2020-10-11 | 2025-11-24 |
| Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen. Cefazolin - Infection Prosthesis Hip and Knee, Infection, Prosthesis Related | Phase 3 | Unknown | Radboud University Medical Center | 751 | 2019-01-01 | 2024-05-07 |
| Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter. Cefazolin - Peritoneal Dialysis-associated Peritonitis, Peritoneal Dialysis Catheter Infection | Phase 3 | Unknown | Carmel Medical Center | 200 | 2017-03-08 | 2023-02-13 |
| Preventive Antibiotic Serum Levels During Caesarean Section Blood samples., Cefazolin - Blood Antibiotic Levels | Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 250 | 2016-08-01 | 2016-07-20 |
| Swiss PACK-CXL Multicenter Trial for the Treatment of Infectious Keratitis PACK-CXL, Cefazolin in combination with either tobramycin or gentamicin, Cycloplegic agents (cyclopentolate 1% eye drops) - Keratitis; Infectious Disease (Manifestation) | Phase 3 | Completed | University Hospital, Geneva | 35 | 2016-03-01 | 2020-10-20 |
| Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis Dalbavancin, cefazolin, nafcillin, oxacillin or vancomycin - Osteomyelitis | Phase 3 | Withdrawn | Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) | 2016-03-01 | 2016-09-23 | |
| Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection Beta-Lactam - Methicillin-Resistant Staphylococcus Aureus | Phase 3 | Terminated | Menzies School of Health Research | 358 | 2015-08-26 | 2018-12-19 |
| Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012) Tedizolid Phophate, Antibiotic comparator, Aztreonam - Skin Diseases, Infectious, Skin Diseases, Bacterial | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 120 | 2015-03-25 | 2019-08-07 |
| Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer Ciprofloxacin, Cefazolin - Prostate Cancer | Phase 3 | Terminated | CR-CSSS Champlain-Charles-Le Moyne | 158 | 2015-02-10 | 2025-02-12 |
| A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial Telavancin, Vancomycin, Daptomycin - Bacteremia | Phase 3 | Terminated | Cumberland Pharmaceuticals | 121 | 2014-12-01 | 2020-02-17 |
| Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy cephalosporins, Fluoroquinolones, Clindamycin - Kidney Stones | Phase 3 | Completed | Northwell Health | 98 | 2014-09-01 | 2023-09-06 |
| Staphylococcus Aureus Bacteremia Antibiotic Treatment Options Trimethoprim-Sulfamethoxazole, Clindamycin, Linezolid - Staphylococcus Aureus Infection | Phase 3 | Completed | Heinrich-Heine University, Duesseldorf | 215 | 2013-12-01 | 2020-05-27 |
| Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) 24-Hour Prophylactic Cefazolin* Antibiotic Regimen, 5-Days Prophylactic Cefazolin* Antibiotic Regimen - Infection, Bone Neoplasms | Phase 3 | Completed | McMaster University | 602 | 2013-01-01 | 2021-03-11 |
| Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane Cefazolin, Clarithromycin - Preterm Premature Rupture of Membrane | Phase 3 | Completed | Samsung Medical Center | 151 | 2011-10-01 | 2022-04-20 |
| Prevention of Arrhythmia Device Infection Trial (PADIT Pilot) Cefazolin, Bacitracin, Cefalexin, Cefazolin - Arrythmias | Phase 3 | Completed | Population Health Research Institute | 500 | 2009-12-01 | 2013-05-16 |
| Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device cefazolin Sodium, placebo - Solid Tumor | Phase 3 | Completed | Istanbul University | 150 | 2008-09-01 | 2010-06-02 |
Showing 20 of 27. Sign in to see all of them.
Infections (4) · Surgical Wound Infection (4) · Staphylococcal Infections (3) · Bacteremia (2) · Preterm Premature Rupture of the Membranes (2) · Sepsis (2) · Wound Infection (2) · Bone Neoplasms (1) · Breast Neoplasms (1) · Cellulitis (1) · Communicable Diseases (1) · Emergencies (1) · Fetal Membranes, Premature Rupture (1) · Hemopneumothorax (1) · Hernia, Inguinal (1)
Samsung Medical Center (2) · Assistance Publique - Hôpitaux de Paris (1) · CR-CSSS Champlain-Charles-Le Moyne (1) · Carmel Medical Center (1) · Clinical Research Centre, Malaysia (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Cumberland Pharmaceuticals (1) · Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) (1) · Heinrich-Heine University, Duesseldorf (1) · Hospital Italiano de Buenos Aires (1) · Istanbul University (1) · McMaster University (1) · MemorialCare (1) · Menzies School of Health Research (1) · Mikkel Herly (1)
United States (5) · Canada (4) · France (3) · Netherlands (3) · Argentina (2) · Australia (2) · Israel (2) · Singapore (2) · South Korea (2) · Spain (2) · Austria (1) · Brazil (1) · Denmark (1) · Egypt (1) · Germany (1)
Achim J Kaasch, MD (1) · Alena Jamdourek, MD (1) · Bart-Jan Kullberg, prof. Dr (1) · Dr. Andrew Krahn (1) · Farhad Hafezi, MD, PhD (1) · Hasan Karanlik, MD (1) · Jose M Cernadas, M.D. (1) · Joshua Davis, MBBS, FRACP (1) · Kenneth Chan, MD (1) · Marc Garnier, MD, PhD (1) · Marjory Jolicoeur, MD,MSc (1) · Michelle Ghert, MD, FRCSC (1)
PMID 21601826, PMID 23052809, PMID 26452342, PMID 27029920, PMID 30545448, PMID 31806127, PMID 32044943, PMID 32051007, PMID 32557558, PMID 33239101, PMID 33395210, PMID 33743753, PMID 33752752, PMID 34859113, PMID 34989778, PMID 34996516, PMID 36115667, PMID 36746334, PMID 37578113, PMID 38244557
2014 (1), 2025 (1)